Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Nuofeite Biological Pharmaceutical Technology is a biotechnology company based in Chengdu, China, specializing in the research, development, and production of biological products for animal health. The company leverages advanced recombinant protein expression platforms, including E. coli, yeast, and baculovirus systems, to develop high-quality vaccines and diagnostic reagents targeting major livestock diseases. Their portfolio includes diagnostic kits for African Swine Fever and various recombinant subunit vaccines designed to improve agricultural biosecurity. Nuofeite operates out of the Chengdu Medical City and provides technical services such as protein expression and purification for the broader life sciences industry. The firm focuses on addressing critical challenges in the swine industry through integrated molecular biology and immunology solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 四川诺非特生物药业科技.